Free Trial

Promising Nuclear Stocks To Keep An Eye On - September 26th

Oklo logo with Energy background

Key Points

  • Seven nuclear stocks including Oklo, Centrus Energy, and NuScale Power are highlighted as promising investment opportunities, reflecting growing interest in low-carbon energy sources.
  • Oklo Inc. specifically focuses on designing fission power plants and recycling used nuclear fuel, positioning itself as a potentially significant player in the nuclear energy market.
  • Centrus Energy supplies nuclear fuel components internationally and operates in two main segments, which allows it to cater to diverse market needs in the nuclear power industry.
  • Five stocks we like better than Oklo.

Oklo, Centrus Energy, NuScale Power, Nano Nuclear Energy, BWX Technologies, Lightbridge, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat's stock screener tool. Nuclear stocks are equities of companies involved in the nuclear energy value chain—ranging from uranium mining and fuel processing to the construction, operation and servicing of nuclear power plants and related technologies. Investors in these stocks seek exposure to a low-carbon energy source whose performance is shaped by regulatory shifts, fuel-price dynamics, technological advances and geopolitical factors. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.

Oklo (OKLO)

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

Read Our Latest Research Report on OKLO

Centrus Energy (LEU)

Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.

Read Our Latest Research Report on LEU

NuScale Power (SMR)

NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.

Read Our Latest Research Report on SMR

Nano Nuclear Energy (NNE)

Read Our Latest Research Report on NNE

BWX Technologies (BWXT)

BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.

Read Our Latest Research Report on BWXT

Lightbridge (LTBR)

Read Our Latest Research Report on LTBR

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).

Read Our Latest Research Report on KPTI

Featured Stories

Should You Invest $1,000 in Oklo Right Now?

Before you consider Oklo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oklo wasn't on the list.

While Oklo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

These Sectors Are On Fire: Breaking Down the Market’s Biggest Gainers
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines